Relationship Network
Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.
Click a node to open it in a new tab
Disease: 13Formula: 24Herb: 12Ingredient: 24Target: 1Links: 73
Arranging relationship network...
Record Fields
Scalar fields from the final target record.
- Target Id
- 515
- Core Entity Id
- Source Entity Count
- 5
- Preferred Name
- CASP1
- Name Cn
- Name Pinyin
- Name En
- caspase 1
- Name Latin
- Bilingual Status
- partial
- Chromosome
- 11
- Map Location
- 11q22.3
- Type Of Gene
- protein-coding
- Organism
- Homo sapiens
- Taxonomy Id
- 9606
- Ttd Target Type
- Clinical Trial target
Names
Preferred names, aliases, and source labels retained in the final schema.
Name
CASP1
Role
gene_symbol
Source
HERB_v2
Preferred
Yes
Name
caspase 1
Role
protein_name
Source
HERB_v2
Preferred
No
Name
ICE
Role
alias
Source
HERB_v2
Preferred
No
Name
IL1BC
Role
alias
Source
HERB_v2
Preferred
No
Name
P45
Role
alias
Source
HERB_v2
Preferred
No
Name
caspase 1
Role
gene_name
Source
SymMap_v2
Preferred
No
Name
Caspase-1
Role
protein_name
Source
SymMap_v2
Preferred
No
Name
Caspase-1
Role
gene_name
Source
ETCM_v2
Preferred
No
Name
caspase 1, apoptosis-related cysteine peptidase (interleukin 1, beta, convertase)
Role
protein_name
Source
TCMBank
Preferred
No
Cross References
Trusted external identifiers retained for this final record.
Hit
T0213
Pdb
1BMQ|1IBC|1ICE|1RWK|1RWM|1RWN|1RWO|1RWP|1RWV|1RWW|1RWX|1SC1|1SC3|1SC4|2FQQ|2H48|2H4W|2H4Y|2H51|2H54|2HBQ|2HBR|2HBY|2HBZ|3D6F|3D6H|3D6M|3E4C|3NS7
Ttd
T98269
Herb
HBTAR000515
Hgnc
1499
Omim
147678
Vega
OTTHUMG00000048072
Tcmsp
TAR00174
Entrez
834477
Sym Map
SMTT00477
Ensembl
ENSG00000137752
Uni Prot
P29466
Etcm Target
163
Gen Bank Gene
X65019
Tcmbank Target
72911889
Gen Bank Protein
33793.0
Attributes
Merged source attributes and domain-specific metadata.
Version
v1,v2
Organism
Homo sapiens
Suppress
0
Chromosome
11
Taxonomy Id
9606
Map Location
11q22.3
Type Of Gene
protein-coding
Ttd Target Type
Clinical Trial target